FDA inspection
Zhejiang Hisun Pharmaceutical Co., Ltd.: FDA inspection ending Jan 19, 2017
FDA inspection 998186 · Voluntary Action Indicated (VAI) · Taizhou
Key facts
| Inspection ID | 998186 |
|---|---|
| Firm | Zhejiang Hisun Pharmaceutical Co., Ltd. |
| FEI number | 3007719313 |
| Address | 46 Waisha Rd., Jiaojiang District |
| City | Taizhou |
| Country | China |
| Fiscal year | 2017 |
| Inspection end date | Jan 19, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data